Abu Dhabi positions itself as global testing ground for AI healthcare solutions

Abu Dhabi is making a bold pitch to become the world's go-to destination for testing AI-powered healthcare technologies. Speaking at the Milken Institute Global Conference in Los Angeles, the emirate's health chief called on global investors and tech companies to use the region as their testing ground.

Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, told the audience that his region offers something unique: a fully integrated healthcare system where AI isn't just talk, but actual infrastructure. 'AI, for us, is not hype, it is a utility,' he said.

What's the news?

Al Mansoori pitched Abu Dhabi as a 'living lab' where healthcare companies can test their products in real-world conditions. The emirate has built what he calls an intelligence-based system that pulls together different types of health data into one platform.

Key features of Abu Dhabi's healthcare system include:

• Integration of genetic data, patient characteristics, and wearable device information
• AI-powered drug discovery programs
• Real-time monitoring through the Unified Medical Operations Command Centre (UMOC)
• AI agents that provide '40 times the manpower' for detecting health incidents
• Emergency care that starts in ambulances

The system has shifted from treating illness to preventing it. 'The future of health will be on sensing,' Al Mansoori explained. 'You need to sense to detect smarter and to intervene in illness earlier before it becomes a disease.'

Why does it matter?

This move puts Abu Dhabi in direct competition with other regions trying to become healthcare innovation hubs. The emirate is betting that its integrated approach and government backing will attract companies looking for real-world testing environments.

For healthcare companies, Abu Dhabi offers something valuable: the ability to see how their products perform with actual patients and real data, rather than just lab conditions. The integrated system means companies can track their products' impact across the entire healthcare chain.

The timing is significant as the global healthcare AI market continues to grow rapidly, with companies seeking places to test and validate their technologies before wider rollouts.

The context

Abu Dhabi's healthcare push fits into the UAE's broader economic diversification strategy. The country is trying to reduce its dependence on oil by becoming a hub for high-tech industries, including healthcare innovation.

The emirate has advantages that many other regions lack: significant capital reserves, government backing, and a relatively small, contained population that makes it easier to implement system-wide changes. Al Mansoori noted that 'Abu Dhabi's long-term plan in health, and in general, is grounded in economic diversification, strategic investment in technology and infrastructure.'

Other countries and regions are making similar plays. Singapore, Israel, and parts of Scandinavia have all positioned themselves as healthcare innovation testbeds. Abu Dhabi's challenge will be proving it can deliver on its promises while competing with these established players.

During the conference, Al Mansoori also met with leaders in longevity research, biotechnology, and genomics to discuss financing models for long-term health outcomes - suggesting the emirate is thinking beyond just attracting individual companies to building an entire ecosystem.